Table 2. Clinical, immunological, and nutritional characteristics of HIV infected children receiving ART at Debre-Markos Referral Hospital, Northwest Ethiopia, 2019.
| Variables | Frequency (N) | Percentage (%) |
|---|---|---|
| Baseline OIs | ||
| Yes | 215 | 52.7 |
| No | 193 | 47.3 |
| Functional status (age ≥ 5 years)(287) | ||
| Working | 153 | 53.3 |
| Ambulatory | 113 | 39.4 |
| Bedridden | 21 | 7.3 |
| Developmental status (age < 5 year) (121) | ||
| Appropriate | 73 | 60.3 |
| Delayed | 41 | 33.9 |
| Regressed | 7 | 5.8 |
| WHO clinical staging | ||
| Stage I and II | 212 | 52.0 |
| Stage III and IV | 196 | 48.0 |
| CD4 counts or CD4% at baseline | ||
| Below the threshold | 132 | 32.4 |
| Above the threshold | 276 | 67.6 |
| Level hemoglobin | ||
| Anemic (< 10 mg/dl) | 47 | 11.5 |
| Non-anemic (≥ 10 mg/dl) | 361 | 88.5 |
| OI prophylaxis given | ||
| Yes | 248 | 60.8 |
| No | 160 | 39.2 |
| Baseline ART regimens | ||
| EFV or NVP based | 370 | 90.7 |
| PI based | 38 | 9.3 |
| OIs during follow-up | ||
| Yes | 120 | 29.4 |
| No | 288 | 70.6 |
| ART eligibility criteria | ||
| Immunologic or Clinical | 341 | 83.6 |
| Test and treat | 67 | 16.4 |
| ART adherence in last three months | ||
| Good | 321 | 78.7 |
| Fair/poor | 87 | 21.3 |
| ART drug side-effects | ||
| Yes | 20 | 4.9 |
| No | 388 | 95.1 |
| Regimen change | ||
| Yes | 85 | 20.8 |
| No | 323 | 79.2 |
| Treatment failure | ||
| Yes | 20 | 4.9 |
| No | 288 | 95.1 |
| Underweight | ||
| Normal | 207 | 50.7 |
| Underweight | 210 | 49.3 |
| Stunting | ||
| Normal | 197 | 48.3 |
| Stunted | 211 | 51.7 |
| Wasting | ||
| Normal | 308 | 75.5 |
| Wasted | 100 | 24.5 |